Business Segments · D&A
Medical Essentials — D&A
Becton, Dickinson and Company Medical Essentials — D&A increased by 4.3% to $147.00M in Q1 2026 compared to the prior quarter.
Analysis
How to read this metric
An increase often signals significant recent capital investment in manufacturing infrastructure or the amortization of acquired technology, whereas a decrease may indicate aging assets or reduced capital expenditure.
Detailed definition
This metric reflects the non-cash expense allocated to the Medical Essentials segment for the wear and tear of tangible...
Peer comparison
Similar to depreciation and amortization charges reported by peer healthcare manufacturing segments, often correlated with the scale of the segment's production facilities.
Metric ID:
bdx_segment_medical_essentials_depreciation_and_amortizationHistorical Data
4 periods
| Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $135.00M | $136.00M | $141.00M | $147.00M |
| QoQ Change | — | +0.7% | +3.7% | +4.3% |
| YoY Change | — | — | +4.4% | +8.1% |
Range$135.00M – $147.00M
Avg YoY Growth+6.3%
Median YoY Growth+6.3%
Current Streak3+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's medical essentials — d&a?
- Becton, Dickinson and Company (BDX) reported medical essentials — d&a of $147.00M in Q1 2026.
- What does medical essentials — d&a mean?
- The total non-cash expense recognized for the aging of equipment and intangible assets within the Medical Essentials segment.